Sager, U., Norin, S., Hatesuer, B. (2025). Comprehensive cost analysis of 4th line + therapies for relapsed/refractory multiple myeloma in Germany: Drug, co-medication, and office-based treatment perspective. Blood. https://doi.org/10.1182/blood-2025-7918